Why Addressing Diabetes is Essential for Effective Tuberculosis Control Efforts

• Diabetes and TB Risk: Diabetes mellitus (DM) increases susceptibility to tuberculosis (TB) and shares common risk factors like older age, unemployment, and low educational status.
• Mechanisms of Susceptibility: The exact mechanisms by which DM heightens TB risk are unclear, but impaired immune responses in diabetics may contribute.
• TB in Diabetic Patients: TB patients with DM are generally older, predominantly male, and have more comorbidities such as hypertension and cardiovascular disease.
• Higher Smear Positivity: Diabetic TB patients exhibit higher rates of AFB positivity on sputum smear tests, especially among those with uncontrolled diabetes.
• Cavitary Lesions: Diabetics, particularly those with uncontrolled diabetes, have more cavitary lesions and require extended treatment durations.
• Public Health Focus: Effective TB elimination strategies must include interventions for DM, as it is expected to rise in areas with significant TB burdens.
• Diagnostic Efficiency: Tests requiring fewer visits can reduce costs, minimize follow-up losses, and improve early TB detection, which is crucial for better outcomes.
• New Diagnostic Tools: While faster diagnostics reduce lab delays, they may create bottlenecks elsewhere in the healthcare system and must be implemented thoughtfully.
• Role of GIS: Geographic Information Systems (GIS) can document MDR TB outbreaks, providing insight into TB’s spread, especially in resource-limited settings.
• Low-Cost Georeferencing: The accessibility of tools like Google Earth makes GIS a valuable, low-cost resource for TB tracking and targeted intervention.
• Social Determinants of TB: Global TB strategies tend to emphasize biomedical solutions, often neglecting the socioeconomic factors that drive TB transmission and impact.
• Need for Integrated Coverage: There is a need for universal health and social coverage (UHSC) that addresses the socioeconomic impacts of TB, such as catastrophic costs, stigma, and undernutrition.

References:

1. Baker, M.A., Lin, H.H., Chang, H.Y. and Murray, M.B., 2012. The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study. Clinical Infectious Diseases, 54(6), pp.818-825.
2. Park, S.W., Shin, J.W., Kim, J.Y., Park, I.W., Choi, B.W., Choi, J.C. and Kim, Y.S., 2012. The effect of diabetic control status on the clinical features of pulmonary tuberculosis. European journal of clinical microbiology & infectious diseases, 31, pp.1305-1310.
3. Lin, H.H., Langley, I., Mwenda, R., Doulla, B., Egwaga, S., Millington, K.A., Mann, G.H., Murray, M., Squire, S.B. and Cohen, T., 2011. A modelling framework to support the selection and implementation of new tuberculosis diagnostic tools. The International journal of tuberculosis and lung disease, 15(8), pp.996-1004.
4. Lin, H., Shin, S., Blaya, J.A., Zhang, Z., Cegielski, P., Contreras, C., Asencios, L., Bonilla, C., Bayona, J., Paciorek, C.J. and Cohen, T., 2011. Assessing spatiotemporal patterns of multidrug-resistant and drug-sensitive tuberculosis in a South American setting. Epidemiology & Infection, 139(11), pp.1784-1793.
5. Fuady, A., Hutanamon, T., Herlinda, O., Luntungan, N. and Wingfield, T., 2024. Achieving universal social protection for people with tuberculosis. The Lancet Public Health, 9(5), pp.e339-e344.

TBC 012